SCHEMBL5316246

SCHEMBL5316246

CCc1cn(CC)nc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.40
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 3/20 0.34
RAB9A P51151 2/20 0.33
POLB P06746 2/20 0.33
COMT P21964 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
GAA P10253 1/20 0.30
KDR P35968 5/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31052657 0.82 KDR (0.37) L3MBTL1KDR
SCHEMBL31052595 0.79 ALDH1A1 (0.33) ALDH1A1HTTPOLBADORA2AADORA2B
SCHEMBL31052416 0.79 ADA (0.31) KDR
SCHEMBL28892524 0.77
SCHEMBL15174556 0.76 KMT2A (0.39) L3MBTL1ALDH1A1RECQLSMN1; SMN2LMNA
SCHEMBL17690981 0.76
SCHEMBL20292234 0.76
SCHEMBL7118318 0.76 L3MBTL1 (0.44) L3MBTL1ALDH1A1KDM4ENPC1RECQL
SCHEMBL1361978 0.76 L3MBTL1 (0.62) L3MBTL1ALDH1A1KDM4ENPC1RECQL
SCHEMBL19592225 0.75 L3MBTL1 (0.41) L3MBTL1ALDH1A1KDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476664-A New compound as autotaxin inhibitors and the pharmaceutical composition comprising it 乐高化学生物科学股份有限公司 2019-03-15 CN disclosed
EP-1861372-A1 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-05 EP disclosed
WO-2006091674-A1 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-08-31 WO disclosed
US-5475114-A Angiotensin-11 antagonist; therapeutical agent used for treating hypertension and chronic heart failure YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-12-12 US disclosed
EP-0646584-A1 PYRAZOLOTRIAZOLE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1995-04-05 EP disclosed